SHE:001367 Revenue

Zhejiang Haisen Pharmaceutical had revenue of 118.48M CNY in the quarter ending March 31, 2025, with 2.32% growth. This brings the company's revenue in the last twelve months to 474.19M, up 16.71% year-over-year. In the year 2024, Zhejiang Haisen Pharmaceutical had annual revenue of 471.51M with 18.63% growth.

Revenue (ttm)

474.19M

Revenue Growth

+16.71%

P/S Ratio

7.82

Revenue / Employee

758.61K

Employees

663

Market Cap

3.93B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	471.51M	74.06M	18.63%
Dec 31, 2023	397.45M	-25.32M	-5.99%
Jan 1, 2023	422.78M	33.79M	8.69%
Dec 31, 2021	388.98M	104.18M	36.58%
Dec 31, 2020	284.80M	18.47M	6.94%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	41.48B
Sichuan Biokin Pharmaceutical	5.82B
Aier Eye Hospital Group	21.81B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings